Literature DB >> 21771955

Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients.

Hervé Gouya1, Olivier Vignaux, Philippe Sogni, Vincent Mallet, Ammar Oudjit, Stanislas Pol, Paul Legmann.   

Abstract

PURPOSE: To validate magnetic resonance (MR) imaging cine phase-contrast blood flow mapping in vitro and in patients with chronic liver disease, with or without portal hypertension, and to assess the accuracy of azygos, splanchnic, and systemic blood flow measured with MR imaging in the detection of high-risk esophageal varices and compare these measurements with endoscopic evaluation, the reference standard.
MATERIALS AND METHODS: The local ethics committee approved this study. Patients gave written informed consent. Two phantoms were used to validate the MR imaging phase-contrast flow sequence. Patients with liver cirrhosis (n = 59), chronic liver disease without cirrhosis (n = 12), and nodular regenerative hyperplasia (NRH) (n = 11), and healthy control subjects with no liver disease (n = 25) were included. The patients underwent upper digestive system endoscopy. Mean abdominal aorta, portal venous, and azygos blood flow was measured on MR images, which were reviewed by two blinded observers to determine the presence and grade of esophageal varices. The reproducibility and intra- and interobserver variability of the blood flow measurements were assessed with intraclass correlation coefficients (ICCs). The performance of the MR blood flow measurements in staging high-risk varices was determined with receiver operating characteristic curve analysis. The correlation between MR visual analysis and endoscopic grading was assessed by using κ statistics.
RESULTS: MR flow rate measurements had excellent correlations with actual flow values in vitro (ICC > 0.990 for phantoms 1 and 2). Mean aortic flow was significantly higher in patients with cirrhosis than in control subjects (P < .001). Mean azygos flow was significantly higher in patients with cirrhosis than in patients with chronic liver disease without cirrhosis (P = .005) and control subjects (P < .001). Low intra- and interobserver variability (ICC > 0.990 for each blood flow type) and high reproducibility (ICC > 0.850 for each blood flow type) were demonstrated. The optimal cutoff mean azygos flow value was 2.3 mL/sec for varices with grades of 2 or higher.
CONCLUSION: MR imaging azygos flow measurement appears to be a promising technique for detecting high-risk esophageal varices in patients with portal hypertension. © RSNA, 2011.

Entities:  

Mesh:

Year:  2011        PMID: 21771955     DOI: 10.1148/radiol.11101541

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.

Authors:  Hervé Gouya; Sophie Grabar; Olivier Vignaux; Anastasia Saade; Stanislas Pol; Paul Legmann; Philippe Sogni
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

Review 2.  Four-dimensional flow magnetic resonance imaging in cirrhosis.

Authors:  Zoran Stankovic
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Reproducibility study of four-dimensional flow MRI of arterial and portal venous liver hemodynamics: influence of spatio-temporal resolution.

Authors:  Zoran Stankovic; Bernd Jung; Jeremy Collins; Maximilian F Russe; James Carr; Wulf Euringer; Lena Stehlin; Zoltan Csatari; Peter C Strohm; Mathias Langer; Michael Markl
Journal:  Magn Reson Med       Date:  2013-09-09       Impact factor: 4.668

Review 4.  Noninvasive imaging assessment of portal hypertension.

Authors:  Paul Kennedy; Octavia Bane; Stefanie J Hectors; Aaron Fischman; Thomas Schiano; Sara Lewis; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2020-09-14

5.  Hemodynamic measurements with an abdominal 4D flow MRI sequence with spiral sampling and compressed sensing in patients with chronic liver disease.

Authors:  Octavia Bane; Steven Peti; Mathilde Wagner; Stefanie Hectors; Hadrien Dyvorne; Michael Markl; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2018-10-14       Impact factor: 4.813

6.  Effect of temporal resolution on 4D flow MRI in the portal circulation.

Authors:  Benjamin R Landgraf; Kevin M Johnson; Alejandro Roldán-Alzate; Christopher J Francois; Oliver Wieben; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

7.  Four-dimensional Flow MRI as a Marker for Risk Stratification of Gastroesophageal Varices in Patients with Liver Cirrhosis.

Authors:  Utaroh Motosugi; Alejandro Roldán-Alzate; Peter Bannas; Adnan Said; Sean Kelly; Ryan Zea; Oliver Wieben; Scott B Reeder
Journal:  Radiology       Date:  2018-10-16       Impact factor: 11.105

Review 8.  4D Flow MRI in the portal venous system: imaging and analysis methods, and clinical applications.

Authors:  Ryota Hyodo; Yasuo Takehara; Shinji Naganawa
Journal:  Radiol Med       Date:  2022-09-19       Impact factor: 6.313

9.  Quantitative liver MRI combining phase contrast imaging, elastography, and DWI: assessment of reproducibility and postprandial effect at 3.0 T.

Authors:  Guido H Jajamovich; Hadrien Dyvorne; Claudia Donnerhack; Bachir Taouli
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

10.  Use of Caval Subtraction 2D Phase-Contrast MR Imaging to Measure Total Liver and Hepatic Arterial Blood Flow: Preclinical Validation and Initial Clinical Translation.

Authors:  Manil D Chouhan; Rajeshwar P Mookerjee; Alan Bainbridge; Simon Walker-Samuel; Nathan Davies; Steve Halligan; Mark F Lythgoe; Stuart A Taylor
Journal:  Radiology       Date:  2016-05-12       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.